Last updated on October 2018

Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan


Brief description of study

The purpose of this post-marketing survey is to obtain real-world information on the safety and effectiveness of evolocumab in Japan.

Detailed Study Description

The objectives of study are to 1) determine the incidence of adverse events and adverse drug reactions among patients receiving evolocumab for up to 2 years, and 2) identify and describe patient characteristics (e.g. demographics, medical history) associated with the safety and effectiveness of evolocumab therapy for the patients with Familial Hypercholesterolemia (Heterozygous or Homozygous) and Hypercholesterolemia in Japan

Clinical Study Identifier: NCT02808403

Find a site near you

Start Over

Research Site

Nagoya city, Japan
1.78miles
  Connect »

Research Site

Komaki city, Japan
9.07miles
  Connect »

Research Site

Tsushima city, Japan
9.52miles
  Connect »

Research Site

Kasugai city, Japan
9.65miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.